rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-2-1
|
pubmed:abstractText |
Chronic thromboembolic pulmonary hypertension (CTEPH) has a dismal prognosis when there are no central pulmonary thrombi amenable to surgical thromboendarterectomy. Pulmonary vasodilators could be useful in this setting. Initial experience with bosentan in a small group of patients with CTEPH has shown favourable results on the short term (3 to 6 months), but long-term effects remain unknown.
|
pubmed:commentsCorrections |
|
pubmed:language |
spa
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0025-7753
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
12-4
|
pubmed:dateRevised |
2008-2-29
|
pubmed:meshHeading |
pubmed-meshheading:17266886-Administration, Oral,
pubmed-meshheading:17266886-Antihypertensive Agents,
pubmed-meshheading:17266886-Chronic Disease,
pubmed-meshheading:17266886-Data Interpretation, Statistical,
pubmed-meshheading:17266886-Female,
pubmed-meshheading:17266886-Follow-Up Studies,
pubmed-meshheading:17266886-Humans,
pubmed-meshheading:17266886-Hypertension, Pulmonary,
pubmed-meshheading:17266886-Male,
pubmed-meshheading:17266886-Middle Aged,
pubmed-meshheading:17266886-Pulmonary Embolism,
pubmed-meshheading:17266886-Retrospective Studies,
pubmed-meshheading:17266886-Sulfonamides,
pubmed-meshheading:17266886-Time Factors,
pubmed-meshheading:17266886-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
[Role of bosentan in patients with chronic venous thromboembolic pulmonary hypertension].
|
pubmed:affiliation |
Unidad de Trasplante Cardíaco e Hipertensión Pulmonar, Hospital Universitario Puerta de Hierro, San Martín de Porres 4, 28035 Madrid, Spain. jsecu@telefonica.net
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract
|